These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10193804)

  • 21. Imaging of apoptosis (programmed cell death) with 99mTc annexin V.
    Blankenberg FG; Katsikis PD; Tait JF; Davis RE; Naumovski L; Ohtsuki K; Kopiwoda S; Abrams MJ; Strauss HW
    J Nucl Med; 1999 Jan; 40(1):184-91. PubMed ID: 9935075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annexin V as a probe of the contribution of anionic phospholipids to the procoagulant activity of tumour cell surfaces.
    Sugimura M; Donato R; Kakkar VV; Scully MF
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):365-73. PubMed ID: 8075308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic action of annexin V proved as efficient as direct inhibition of tissue factor or thrombin.
    Galán AM; van Heerde WL; Escolar G; Ordinas A; Sixma J; de Groot PG
    Eur J Clin Invest; 2006 Sep; 36(9):633-9. PubMed ID: 16919046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
    Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
    Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5.
    Dasgupta SK; Guchhait P; Thiagarajan P
    Transl Res; 2006 Jul; 148(1):19-25. PubMed ID: 16887494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary procoagulant activity and tissue factor levels in patients with diabetes mellitus.
    Qi H; Koyama T; Nishida K; Miyasaka N; Hirosawa S
    Haemostasis; 1997; 27(2):57-64. PubMed ID: 9212353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oyxsterols induce membrane procoagulant activity in monocytic THP-1 cells.
    Aupeix K; Toti F; Satta N; Bischoff P; Freyssinet JM
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):1027-33. PubMed ID: 8615754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cytoplasmic domain of tissue factor restricts physiological albuminuria and pathological proteinuria associated with glomerulonephritis in mice.
    Apostolopoulos J; Moussa L; Tipping PG
    Nephron Exp Nephrol; 2010; 116(4):e72-83. PubMed ID: 20664298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Annexin V inhibition of factor IXa-catalyzed factor X activation on human platelets and on negatively-charged phospholipid vesicles.
    London F; Ahmad SS; Walsh PN
    Biochemistry; 1996 Dec; 35(51):16886-97. PubMed ID: 8988028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of the mechanism for enhanced cell surface factor VIIa/tissue factor activation of factor X on fibroblast monolayers after their exposure to N-ethylmaleimide.
    Le DT; Rapaport SI; Rao LV
    Thromb Haemost; 1994 Dec; 72(6):848-55. PubMed ID: 7740453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human cytosolic phospholipase A2 by human annexin V.
    Buckland AG; Wilton DC
    Biochem J; 1998 Jan; 329 ( Pt 2)(Pt 2):369-72. PubMed ID: 9425121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Placenta and annexin V receptors, antibodies against annexin V and against other phospholipids in patients with recurrent pregnancy loss].
    Ulcová-Gallová Z; Mukengnábl P; Hadravská S; Bibková K; Slechtová J; Kyselová V; Micanová Z; Rokyta Z
    Ceska Gynekol; 2006 Dec; 71(6):469-73. PubMed ID: 17236406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary tissue factor activity in colorectal disease.
    Carty N; Taylor I; Roath OS; el-Baruni K; Francis JL
    Br J Surg; 1990 Oct; 77(10):1091-4. PubMed ID: 2224454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrasting effects of gentamicin and mercuric chloride on urinary excretion of enzymes and phospholipids in the rat.
    Josepovitz C; Levine R; Lane B; Kaloyanides GJ
    Lab Invest; 1985 Apr; 52(4):375-86. PubMed ID: 2858601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ApoCorrect assay: a novel, rapid method to determine the biological functionality of radiolabeled and fluorescent Annexin A5.
    Boersma HH; Stolk LM; Kenis H; Deckers NM; Vanderheyden JL; Hofstra L; Heidendal GA; Reutelingsperger CP
    Anal Biochem; 2004 Apr; 327(1):126-34. PubMed ID: 15033520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
    Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
    Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy.
    Thuraisingham RC; Nott CA; Dodd SM; Yaqoob MM
    Kidney Int; 2000 May; 57(5):1968-72. PubMed ID: 10792615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of lipid composition and divalent cations on annexin V binding to phospholipid mixtures.
    Maffey KG; Keil LB; DeBari VA
    Ann Clin Lab Sci; 2001 Jan; 31(1):85-90. PubMed ID: 11314866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrastructural detection of surface exposed phosphatidylserine on activated blood platelets.
    Stuart MC; Bevers EM; Comfurius P; Zwaal RF; Reutelingsperger CP; Frederik PM
    Thromb Haemost; 1995 Oct; 74(4):1145-51. PubMed ID: 8560427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface.
    Kunzelmann-Marche C; Satta N; Toti F; Zhang Y; Nawroth PP; Morrissey JH; Freyssinet JM
    Thromb Haemost; 2000 Feb; 83(2):282-9. PubMed ID: 10739387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.